53 related articles for article (PubMed ID: 20230671)
1. [Neurotoxicity effect of MPP+ on primary cultured mesencephalon neurons of SAMP8 mouse].
Liu J; Liu JQ; Liu L; Ma L; Wang YY; Ma QY; Wang MW
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):129-31. PubMed ID: 20230671
[TBL] [Abstract][Full Text] [Related]
2. A morphometric analysis of bipolar and multipolar TH-IR neurons treated with the neurotoxin MPP+ in co-cultures from mesencephalon and striatum of embryonic C57BL/6 mice.
Koutsilieri E; Chen TS; Kruzik P; Rausch WD
J Neurosci Res; 1995 Jun; 41(2):197-205. PubMed ID: 7650755
[TBL] [Abstract][Full Text] [Related]
3. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
4. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
Mena MA; Casarejos MJ; García de Yébenes J
J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
[TBL] [Abstract][Full Text] [Related]
5. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study.
Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF
Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336
[TBL] [Abstract][Full Text] [Related]
7. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
8. K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production.
Xie J; Duan L; Qian X; Huang X; Ding J; Hu G
J Neurosci Res; 2010 Feb; 88(2):428-37. PubMed ID: 19746425
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
[TBL] [Abstract][Full Text] [Related]
10. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
Otto D; Unsicker K
J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
Nagel F; Bähr M; Dietz GP
Brain Res Bull; 2009 Jun; 79(5):303-9. PubMed ID: 19406215
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures.
Friedman LK; Mytilineou C
J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 beta enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons.
Akaneya Y; Takahashi M; Hatanaka H
Exp Neurol; 1995 Nov; 136(1):44-52. PubMed ID: 7589333
[TBL] [Abstract][Full Text] [Related]
14. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
[TBL] [Abstract][Full Text] [Related]
15. Rifampicin inhibits neurodegeneration in the optic nerve transection model in vivo and after 1-methyl-4-phenylpyridinium intoxication in vitro.
Kilic U; Kilic E; Lingor P; Yulug B; Bähr M
Acta Neuropathol; 2004 Jul; 108(1):65-8. PubMed ID: 15138778
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.
Sanchez-Ramos J; Facca A; Basit A; Song S
Exp Neurol; 1998 Apr; 150(2):263-71. PubMed ID: 9527896
[TBL] [Abstract][Full Text] [Related]
17. A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons.
Lin LF; Rubin LL; Xu M
J Neurochem; 2004 Jun; 89(6):1387-95. PubMed ID: 15189341
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
19. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons.
Hashimoto T; Nishi K; Nagasao J; Tsuji S; Oyanagi K
Brain Res; 2008 Mar; 1197():143-51. PubMed ID: 18242592
[TBL] [Abstract][Full Text] [Related]
20. Survival of and 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity against dopaminergic neurons in coculture of rat mesencephalon with their target on non-target regions.
Akaneya Y; Takahashi M; Hatanaka H
Neurosci Res; 1995 Aug; 23(1):55-63. PubMed ID: 7501301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
